ArticleBMB reports2018

HSP90 inhibitor, AUY922, debilitates intrinsic and acquired lapatinib-resistant HER2-positive gastric cancer cells.

Kang-Seo Park et al.PubMed ↗Full text ↗

No numbers read from the abstract.